Development of Hypoxia in a Preclinical Model of Tumor Micrometastases

International Journal of Radiation Oncology Biology Physics

Volumn 76, Issue 3, 2010, Pages 879-888

  Simonsen, Trude G ^a   Gaustad, Jon Vidar ^a   Rofstad, Einar K ^a  

^a INSTITUTE OF CANCER RESEARCH   (Norway)

Author keywords

Blood supply; Hypoxia; Melanoma; Micrometastases; Vascular morphology

Indexed keywords

BLOOD FLOW; BLOOD FLOW VELOCITY; BLOOD SUPPLY; HIGH GROWTH RATE; HIGH RESISTANCE; HUMAN TUMORS; HYPOXIA MARKER; ISOTHIOCYANATES; LOW GROWTH RATE; SINGLE PARAMETER; TUMOR HYPOXIA; VASCULAR NETWORK; VESSEL SEGMENTS; WINDOW CHAMBERS;

BIOLOGICAL MATERIALS; BLOOD; DERMATOLOGY; FLOW VELOCITY; GLUCOSE; HEMODYNAMICS; MORPHOLOGY; ONCOLOGY; OXYGENATION;

TUMORS;

PIMONIDAZOLE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD FLOW VELOCITY; CANCER GROWTH; FEMALE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HYPOXIA; IMMUNOHISTOCHEMISTRY; MELANOMA; MICROMETASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR VASCULARIZATION; TUMOR VOLUME;

ANIMALS; BLOOD FLOW VELOCITY; CELL HYPOXIA; FEMALE; HUMANS; MELANOMA; MICE; MICE, INBRED A; MICE, NUDE; NITROIMIDAZOLES; RHODAMINES; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 76049112843     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2009.09.045     Document Type: Article

References (22)

1. Höckel M., and Vaupel P. Tumor hypoxia: Definitions and current clinical, biologic, and molecular aspects. J Natl Cancer Inst 93 (2001) 266-276
2. Harris A.L. Hypoxia-A key regulatory factor in tumour growth. Nature Rev Cancer 2 (2002) 38-47
3. Brown J.M., and Giaccia A.J. The unique physiology of solid tumors: Opportunities (and problems) for cancer therapy. Cancer Res 58 (1998) 1408-1416
4. Vaupel P., and Mayer A. Hypoxia in cancer: Significance and impact on clinical outcome. Cancer Metastasis Rev 26 (2007) 225-239
5. Jain R.K. Determinants of tumor blood flow: A review. Cancer Res 48 (1988) 2641-2658
6. Moulder J.E., and Rockwell S. Hypoxic fractions of solid tumors: Experimental techniques, methods of analysis, and a survey of existing data. Int J Radiat Oncol Biol Phys 10 (1984) 695-712
7. Talmadge J.E., Singh R.K., Fidler I.J., et al. Murine models to evaluate novel and conventional therapeutic strategies for cancer. Am J Pathol 170 (2007) 793-804
8. Li X.F., Carlin S., Urano M., et al. Visualization of hypoxia in microscopic tumors by immunofluorescent microscopy. Cancer Res 67 (2007) 7646-7653
9. Gaustad J.V., Brurberg K.G., Simonsen T.G., et al. Tumor vascularity assessed by magnetic resonance imaging and intravital microscopy imaging. Neoplasia 10 (2008) 354-362
10. Brurberg K.G., Gaustad J.V., Mollatt C.S., et al. Temporal heterogeneity in blood supply in human tumor xenografts. Neoplasia 10 (2008) 727-735
11. Rofstad E.K. Orthotopic human melanoma xenograft model systems for studies of tumour angiogenesis, pathophysiology, treatment sensitivity and metastatic pattern. Br J Cancer 70 (1994) 804-812
12. Rofstad E.K., Wahl A., Davies C.L., et al. Growth characteristics of human melanoma multicellular spheroids in liquid-overlay culture: Comparisons with the parent tumour xenografts. Cell Tissue Kinet 19 (1986) 205-216
13. Rofstad E.K., and Måseide K. Radiobiological and immunohistochemical assessment of hypoxia in human melanoma xenografts: Acute and chronic hypoxia in individual tumours. Int J Radiat Biol 75 (1999) 1377-1393
14. Vajkoczy P., Ullrich A., and Menger M.D. Intravital fluorescence videomicroscopy to study tumor angiogenesis and microcirculation. Neoplasia 2 (2000) 53-61
15. Herlyn M. Human melanoma: Development and progression. Cancer Metastasis Rev 9 (1990) 101-112
16. Sutherland R.M. Cell and environment interactions in tumor microregions: The multicell spheroid model. Science 240 (1988) 177-184
17. Barnhill R.L., Piepkorn M.W., Cochran A.J., et al. Tumor vascularity, proliferation, and apoptosis in human melanoma micrometastases and macrometastases. Arch Dermatol 134 (1998) 991-994
18. Cao Y., Li C.Y., Moeller B.J., et al. Observation of incipient tumor angiogenesis that is independent of hypoxia and hypoxia inducible factor-1 activation. Cancer Res 65 (2005) 5498-5505
19. Stanley J.A., Shipley W.U., and Steel G.G. Influence of tumour size on hypoxic fraction and therapeutic sensitivity of Lewis lung tumour. Br J Cancer 36 (1977) 105-113
20. Milas L., Hunter N.M., Ito H., et al. Increase in radiosensitivity of lung micrometastases by hyperbaric oxygen. Clin Exp Metastasis 3 (1985) 21-27
21. Hoogsteen I.J., Marres H.A., van der Kogel A.J., et al. The hypoxic tumour microenvironment, patient selection and hypoxia-modifying treatments. Clin Oncol 19 (2007) 385-396
22. Kaanders J.H., Bussink J., and van der Kogel A.J. Clinical studies of hypoxia modification in radiotherapy. Semin Radiat Oncol 14 (2004) 233-240